Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy
Introduction: The study assesses radiation-induced sensorineural hearing loss (SNHL) in head and neck cancer patients, highlighting the common occurrence of SNHL as a significant side effect of radiation therapy (RT) targeting the cochlea and acoustic pathways. Material and Methods: The study includ...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2024-10-01
|
Series: | Iranian Journal of Medical Physics |
Subjects: | |
Online Access: | https://ijmp.mums.ac.ir/article_24302_0fa044fceee32acb9ccc81e6a5b7a16c.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832595674382729216 |
---|---|
author | Sohaila Yazdani Kolsoum Teimouri Negin Farshchian Karim Khoshgard |
author_facet | Sohaila Yazdani Kolsoum Teimouri Negin Farshchian Karim Khoshgard |
author_sort | Sohaila Yazdani |
collection | DOAJ |
description | Introduction: The study assesses radiation-induced sensorineural hearing loss (SNHL) in head and neck cancer patients, highlighting the common occurrence of SNHL as a significant side effect of radiation therapy (RT) targeting the cochlea and acoustic pathways.
Material and Methods: The study included 34 patients (22 men, 12 women, mean age 40.13 ± 26.8 years) with head and neck cancers undergoing three-dimensional conformal radiation therapy (3D-CRT); 16 also had chemoradiotherapy (CRT). Pure-tone audiometry (PTA: 250-8000 Hz) was done before, immediately after, and three months post-RT for all patients. Hearing impairment was evaluated using the CTCAE 4.03 scoring system.
Results: According to the findings, 19% and 37% of ears experienced SNHL immediately post-RT and 3 months after RT, respectively. The mean cochlear dose was 25.48 ± 13.56 Gy. A significant correlation existed between the cochlear dose and SNHL incidence (P-value < 0.05). Regression analysis indicated the mean cochlear dose as a robust predictor of SNHL, particularly at 8000 Hz (β = 0.570, P-value = 0.0001). Highest SNHL incidence at 8000 Hz, 3 months post-RT. A significant difference in SNHL threshold was observed between men and women at the frequency of 1000 Hz (P-value = 0.024). There was a statistically significant difference in SNHL thresholds between patients who underwent CRT versus those treated with RT alone (P-value < 0.05).
Conclusion: RT commonly causes SNHL in head and neck cancer patients. Mean cochlear dose predicts SNHL, especially at higher frequencies. |
format | Article |
id | doaj-art-427f516431494be783bcd7c13d5c6c04 |
institution | Kabale University |
issn | 2345-3672 |
language | English |
publishDate | 2024-10-01 |
publisher | Mashhad University of Medical Sciences |
record_format | Article |
series | Iranian Journal of Medical Physics |
spelling | doaj-art-427f516431494be783bcd7c13d5c6c042025-01-18T07:29:19ZengMashhad University of Medical SciencesIranian Journal of Medical Physics2345-36722024-10-0121533634210.22038/ijmp.2024.78841.239524302Assessment of Hearing Ability in Patients after Head and Neck Cancer RadiotherapySohaila Yazdani0Kolsoum Teimouri1Negin Farshchian2Karim Khoshgard3Students Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.Students Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranDepartment of Radiation Oncology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranAssociate Professor in Medical Physics, Department of Medical Physics, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranIntroduction: The study assesses radiation-induced sensorineural hearing loss (SNHL) in head and neck cancer patients, highlighting the common occurrence of SNHL as a significant side effect of radiation therapy (RT) targeting the cochlea and acoustic pathways. Material and Methods: The study included 34 patients (22 men, 12 women, mean age 40.13 ± 26.8 years) with head and neck cancers undergoing three-dimensional conformal radiation therapy (3D-CRT); 16 also had chemoradiotherapy (CRT). Pure-tone audiometry (PTA: 250-8000 Hz) was done before, immediately after, and three months post-RT for all patients. Hearing impairment was evaluated using the CTCAE 4.03 scoring system. Results: According to the findings, 19% and 37% of ears experienced SNHL immediately post-RT and 3 months after RT, respectively. The mean cochlear dose was 25.48 ± 13.56 Gy. A significant correlation existed between the cochlear dose and SNHL incidence (P-value < 0.05). Regression analysis indicated the mean cochlear dose as a robust predictor of SNHL, particularly at 8000 Hz (β = 0.570, P-value = 0.0001). Highest SNHL incidence at 8000 Hz, 3 months post-RT. A significant difference in SNHL threshold was observed between men and women at the frequency of 1000 Hz (P-value = 0.024). There was a statistically significant difference in SNHL thresholds between patients who underwent CRT versus those treated with RT alone (P-value < 0.05). Conclusion: RT commonly causes SNHL in head and neck cancer patients. Mean cochlear dose predicts SNHL, especially at higher frequencies.https://ijmp.mums.ac.ir/article_24302_0fa044fceee32acb9ccc81e6a5b7a16c.pdfhead and neck cancerradiation therapysensorineural hearing lossaudiometryside effects |
spellingShingle | Sohaila Yazdani Kolsoum Teimouri Negin Farshchian Karim Khoshgard Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy Iranian Journal of Medical Physics head and neck cancer radiation therapy sensorineural hearing loss audiometry side effects |
title | Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy |
title_full | Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy |
title_fullStr | Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy |
title_full_unstemmed | Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy |
title_short | Assessment of Hearing Ability in Patients after Head and Neck Cancer Radiotherapy |
title_sort | assessment of hearing ability in patients after head and neck cancer radiotherapy |
topic | head and neck cancer radiation therapy sensorineural hearing loss audiometry side effects |
url | https://ijmp.mums.ac.ir/article_24302_0fa044fceee32acb9ccc81e6a5b7a16c.pdf |
work_keys_str_mv | AT sohailayazdani assessmentofhearingabilityinpatientsafterheadandneckcancerradiotherapy AT kolsoumteimouri assessmentofhearingabilityinpatientsafterheadandneckcancerradiotherapy AT neginfarshchian assessmentofhearingabilityinpatientsafterheadandneckcancerradiotherapy AT karimkhoshgard assessmentofhearingabilityinpatientsafterheadandneckcancerradiotherapy |